Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission

Journal of Acquired Immune Deficiency Syndromes

Volumn 30, Issue 4, 2002, Pages 410-412

  Vithayasai, Vicharn ^a   Moyle, Graeme J ^a   Supajatura, Volaluck ^a   Wattanatchariya, Nisit ^a   Kanshana, Siripon ^a   Sirichthaporn, Preecha ^a   Dabtham, Krai ^a   Somburanasin, Pichaya ^a   Chantawuttinan, Tawachai ^a   Hill, Andrew M ^a   Hawkins, David ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Mother to child; Pharmacokinetics; Prevention; Saquinavir; Vertical transmission

Indexed keywords

LAMIVUDINE; SAQUINAVIR; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BLOOD SAMPLING; CANDIDIASIS; CHILDBIRTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENVIRONMENTAL EXPOSURE; HEARTBURN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LYMPHOCYTE COUNT; MALE; MULTICENTER STUDY; NAUSEA; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; STEADY STATE; THAILAND; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME; UNITED KINGDOM; VAGINITIS; VERTICAL TRANSMISSION; VIRUS LOAD; VOMITING;

EID: 0036683493     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200208010-00006     Document Type: Article

References (12)

1. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
2. Antiretroviral therapy in pregnancy: A focus on safety
3. Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study
4. Stimulation of vitamin A(1) acid signaling by the HIV protease inhibitor indinavir
5. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIV- NET 012 randomised trial
6. Experience of nevirapine use in a London cohort of HIV-infected pregnant women
7. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
8. Warning for pregnant women on HIV therapy
9. Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment
10. Chromatographic and immunochemical approaches to the analysis of the HIV protease inhibitor saquinavir in plasma
11. A study of sixty pregnancies in patients with the antiphospholipid syndrome
12. Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients